FIELD: medicine.
SUBSTANCE: present invention refers to pharmaceutics, medicine and organic chemistry and concerns compounds of formulae presented below, as well as a pharmaceutical composition exhibiting NPY Y5 receptor antagonist activity, or an anorectic composition or an anti-obesity composition containing the compound of formulae presented below
EFFECT: what is presented is an amine derivative possessing npy y5 antagonist activity, and application thereof.
5 cl, 1 dwg, 2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF CONDENSED POLYCYCLIC HETEROCYCLIC COMPOUNDS AND METHOD OF THEIR SYNTHESIS | 1996 |
|
RU2167877C2 |
| CONDENSED HETEROCYCLIC DERIVATIVE, THERAPEUTIC COMPOSITION WHICH CONTAINS IT AND ITS APPLICATION IN MEDICINE | 2006 |
|
RU2418803C2 |
| SULFONAMIDE DERIVATIVE AND MEDICINAL USE THEREOF | 2014 |
|
RU2667520C9 |
| GLYCOLATOXIDASE INHIBITORS FOR THE TREATMENT OF DISEASES | 2018 |
|
RU2805308C2 |
| AZALACTAM COMPOUNDS AS HPK1 INHIBITORS | 2019 |
|
RU2801140C2 |
| INDOLE DERIVATIVE AND ITS USE IN THERAPEUTIC PURPOSES | 2008 |
|
RU2477274C2 |
| N,N-SUBSTITUTED 3-AMINOPYRROLIDINE COMPOUNDS EFFECTIVE AS MONOAMINE REUPTAKE INHIBITORS | 2006 |
|
RU2574406C2 |
| PESTICIDE COMPOSITIONS | 2013 |
|
RU2616808C2 |
| DNA-PK INHIBITORS | 2013 |
|
RU2638540C1 |
| ISOINDOLINONE-BASED PHOSPHATIDYLINOSITOL-3-KINASE INHIBITORS | 2010 |
|
RU2573569C2 |
